Skip to main content

Type 2 diabetes


04-19-2018 | Older adults | News

Glycemic variability modifies mortality risk in older diabetes patients

The excess mortality risk associated with high or very low glycated hemoglobin values is modified by glycemic variability in diabetes patients aged 70 years or more, shows an analysis of The Health Improvement Network database.

04-18-2018 | Nephropathy | News

Neprilysin inhibition appears beneficial in diabetic kidney disease

Secondary analysis of the PARADIGM-HF trial shows that the adverse effects of diabetes on kidney function can be ameliorated by a neprilysin inhibitor.

04-17-2018 | Medications | News

Modern antidiabetic medications ranked for survival benefits

A network meta-analysis published in JAMA offers indirect comparisons of the survival benefits associated with use of the most recent antidiabetic agents.

Read more


03-19-2018 | Diet | Editorial | Audio

UK nutrition guidelines: A fresh approach

John Wilding talks to Pamela Dyson about the fresh approach taken to the latest update of the Diabetes UK nutrition guidelines.

03-16-2018 | Obesity | Editorial | Video

The updated Diabetes UK nutrition guidelines: an obesity specialist’s view

John Wilding explains how the latest update of the nutrition guidelines will help clinicians working with patients with obesity.

03-16-2018 | Diet | Editorial | Video

What’s new in the Diabetes UK nutrition guidelines

Dietician Pam Dyson explains why the latest update of the nutrition guidelines is an important departure from previous versions.

In depth

04-17-2018 | Dipeptidyl peptidase-4 inhibitors | At a glance | Article

Round up of the DPP-4 inhibitor CV outcome trials

medwireNews provides a brief overview of the published and ongoing dipeptidyl peptidase-4 inhibitorscardiovascular outcomes trials.

03-27-2018 | Inpatient diabetes | Feature | Article

The inpatient diabetes audit: A tool for change

With the 2017 NaDIA results showing some positive trends in inpatient diabetes care, medwireNews talks to national clinical lead Gerry Rayman about the tools and tactics to deliver the best patient outcomes.

Original research

Journal articles and book chapters

04-05-2018 | Oral combination medications | Review | Article

Combination treatment of SGLT2 inhibitors and GLP-1 receptor agonists: Symbiotic effects on metabolism and cardiorenal risk

Goncalves E, Bell DSH. Diabetes Ther 2018; Advance online publication. doi: 10.1007/s13300-018-0420-6

03-27-2018 | Nephropathy | Review | Article

New diabetes therapies and diabetic kidney disease progression: The role of SGLT-2 inhibitors

Dekkers CCJ, Gansevoort RT, Heerspink HJL. Curr Diab Rep 2018; 18: 27. doi: 10.1007/s11892-018-0992-6

03-26-2018 | Cancer | Review | Article

Epidemiological dimensions of the association between type 2 diabetes and cancer: A review of observational studies

Sacerdote C, Ricceri F. Diabetes Res Clin Prac 2018; Advance online publication. doi: 10.1016/j.diabres.2018.03.002

In practice

06-01-2017 | Type 2 diabetes | Review | Article

Practical recommendations for transitioning patients with type 2 diabetes from hospital to home

Donihi AC. Curr Diab Rep 2017; 17: 52. doi: 10.1007/s11892-017-0876-1

05-08-2017 | Type 1 diabetes | Review | Article

A practical review of C-Peptide testing in diabetes

Leighton E, Sainsbury CA, Jones GC. Diabetes Ther 2017; 8: 475–487. doi: 10.1007/s13300-017-0265-4

04-04-2017 | Screening | Article

Understanding type 2 diabetes mellitus screening practices among primary care physicians: A qualitative chart-stimulated recall study

Hafez D et al. BMC Fam Pract 2017; 18: 50. doi: 10.1186/s12875-017-0623-3

Case reports

03-29-2018 | Pregnancy | Case report | Article

Empagliflozin, metformin, and insulin degludec, during pregnancy: A case report

The authors report the case of a 31-year-old Caucasian woman with type 2 diabetes who conceived while on therapy with empagliflozin plus metformin and insulin degludec.

Formoso G et al. Acta Diabetol 2018; Advance online publication. doi: 10.1007/s00592-018-1134-y

12-08-2016 | Hypoglycemia | Case report | Article


How would you approach the case of this 38-year-old female teacher with Addison’s disease, diabetes and recurrent severe hypoglycemia?

Zammitt NN, Frier BM. In: Endocrinology and Diabetes. Edited by Ajjan R, Orme SM. Springer London, 2015. doi: 10.1007/978-1-4471-2789-5_17

image credits